Skip to content

Andrew Smith

2 papers in the library · 7 citations · publishing 2018-2019

Papers

Sort Most recent Most cited

Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs

Drug Science Policy and Law 2019 Edward James, Thomas L Robertshaw, Michael Pascoe et al. 3 citations

Background: Contemporary research indicates that the legal classifications of cannabis (Schedule 2, Class B), 3,4-methylenedioxymethamphetamine (MDMA) (Schedule 1, Class A) and psilocybin (Schedule 1, Class A) in the United Kingdom are not entirely based on considerations of harm and therapeutic utility. The legal classifications of the substances discussed are typically determined by...

Pharmacies as potential providers of harm reduction services: A preliminary online survey

Drug Science Policy and Law 2018 Edward James, Thomas L Robertshaw, Andrew D. Westwell et al. 4 citations

Background Recreational drug use is a major cause of disease, injury, physical and mental impairment and death in developed countries such as the United Kingdom and the United States. Alcohol, tobacco, cannabis, 3,4-methylenedioxymethamphetamine (MDMA) and psilocybe mushrooms are recreational drugs with capacity to cause harm. Cannabis, MDMA and psilocybin have reported therapeutic...